Form 4 for CADL Candel Therapeutics, Inc.
Accepted 2024-12-13 00:00:00 ET · period of report 2024-12-11 · accession 0001873919-24-000009 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-12-13 | 2024-12-11+ | CADL | Aguilar-Cordova Estuardo | 10% | D - Sale to Iss | $9.28 | -400.0K | 473.5K | -46% | -$3.71M |
| MI | 2024-12-13 | 2024-12-11+ | CADL | Aguilar-Cordova Estuardo | 10% | D - Sale to Iss | $9.28 | -400.0K | 631.4K | -39% | -$3.71M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | CADL | 2024-12-11 | D | D | 200,000 | $8.53 | 673,512 | D By LKA 2022 Revocable Trust | — | — | (F1) Shares of common stock held by spouse LKA 2022 Revocable trust |
| 2 | Common | CADL | 2024-12-12 | D | D | 200,000 | $10.04 | 431,443 | I | — | — | |
| 3 | Common | CADL | 2024-12-12 | D | D | 200,000 | $10.04 | 473,512 | D | — | — | |
| 4 | Common | CADL | 2024-12-11 | D | D | 200,000 | $8.53 | 631,443 | I By LKA 2022 Revocable Trust | — | — | (F1) Shares of common stock held by spouse LKA 2022 Revocable trust |